Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Benedikt Fischer, Wayne Hall, Thiago M. Fidalgo, Eva Hoch, Bernard Le Foll, Maria-Elena Medina-Mora, Jens Reimer, Philip G. Tibbo & Didier Jutras-Aswad. (2023) Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review. Journal of Dual Diagnosis 19:2-3, pages 71-96.
Read now
Read now
Yiyang Liu, JeeWon Cheong, Barry Setlow & Linda B. Cottler. (2021) Cocaine and Marijuana Polysubstance Use and Cocaine Use Disorder: Investigating Mediated Effects through Patterns of Cocaine Use. Journal of Dual Diagnosis 17:1, pages 23-33.
Read now
Read now
Lucia Sideli, Harriet Quigley, Caterina La Cascia & Robin M. Murray. (2020) Cannabis Use and the Risk for Psychosis and Affective Disorders. Journal of Dual Diagnosis 16:1, pages 22-42.
Read now
Read now
Articles from other publishers (46)
Albert Stuart Reece & Gary Kenneth Hulse. (2023) Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome. Frontiers in Psychiatry 14.
Crossref
Crossref
Albert Stuart Reece & Gary Kenneth Hulse. (2023) Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1–aging and epigenomics. Frontiers in Psychiatry 14.
Crossref
Crossref
Helena Gonzalez-Casals, Jaume Vives, Marina Bosque-Prous, Cinta Folch, Gemma Drou-Roget, Carles Muntaner, Carmen Vives-Cases, María Gabriela Barbaglia, Joan Colom & Albert Espelt. (2023) Gender inequalities in the prevalence of low mood and related factors in schooled adolescents during the 2019–2020 school year: DESKcohort project. Journal of Affective Disorders.
Crossref
Crossref
Joshua A. Lile, Brian W. Turner, David H. Cox, Marcel O. Bonn-Miller, Ned R. Katz, Thomas P. Shellenberg, William W. Stoops & Justin C. Strickland. (2023) Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis. Journal of Addiction Medicine 17:2, pages e87-e93.
Crossref
Crossref
Albert Reece & Gary Hulse. (2022) Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis. International Journal of Environmental Research and Public Health 19:24, pages 16721.
Crossref
Crossref
Ismail Rammouz, Mohamed Merzouki, Sara Bouri, Aalouane Rachid, Amine Bout & Saïd Boujraf. (2022) Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study. Central Nervous System Agents in Medicinal Chemistry 22:3, pages 188-197.
Crossref
Crossref
Berta Ramos, Ana Filipa Santos Martins & Eva Sofia Lima Osório. (2022) Psychotic Cannabis Withdrawal: A Clinical Case. Cureus.
Crossref
Crossref
Chantelle T White, Humaira Shamim, Roba Al Shouli, Ahmad B Habbal & Lubna Mohammed. (2022) Cannabis Use and the Development of Depression in Adolescents: Is There an Established Linear Relationship Between the Two?. Cureus.
Crossref
Crossref
Paulo Seabra, Ana Sequeira, Fernando Filipe, Paula Amaral, Ana Simões & Rui Sequeira. (2021) Substance Addiction Consequences: Outpatients Severity Indicators in a Medication-Based Program. International Journal of Mental Health and Addiction 20:3, pages 1837-1853.
Crossref
Crossref
Howard Padwa, David Huang, Larissa Mooney, Christine E. Grella, Darren Urada, Douglas S. Bell, Brittany Bass & Anne E. Boustead. (2022) Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state. Substance Abuse Treatment, Prevention, and Policy 17:1.
Crossref
Crossref
American Psychiatric Association. 2022. Diagnostic and Statistical Manual of Mental Disorders. Diagnostic and Statistical Manual of Mental Disorders.
Laura Prieto-Arenas, Ignacio Díaz & M. Carmen Arenas. (2022) Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review. Brain Sciences 12:3, pages 388.
Crossref
Crossref
Lone Baandrup. (2022) Managing the hazards of cannabis use. Acta Psychiatrica Scandinavica 145:3, pages 231-233.
Crossref
Crossref
Dorothy Wallis, J. Douglas Coatsworth, Jeremy Mennis, Nathaniel R. Riggs, Nikola Zaharakis, Michael A. Russell, Aaron R. Brown, Stephanie Rayburn, Aubrie Radford, Christopher Hale & Michael J. Mason. (2022) Predicting Self-Medication with Cannabis in Young Adults with Hazardous Cannabis Use. International Journal of Environmental Research and Public Health 19:3, pages 1850.
Crossref
Crossref
Oluwakemi Olanike Aderibigbe, Shannon L. Stewart, John P. Hirdes & Christopher Perlman. (2022) Substance Use among Youth in Community and Residential Mental Health Care Facilities in Ontario, Canada. International Journal of Environmental Research and Public Health 19:3, pages 1731.
Crossref
Crossref
Benedikt Fischer, Tessa Robinson, Chris Bullen, Valerie Curran, Didier Jutras-Aswad, Maria Elena Medina-Mora, Rosalie Liccardo Pacula, Jürgen Rehm, Robin Room, Wim van den Brink & Wayne Hall. (2022) Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. International Journal of Drug Policy 99, pages 103381.
Crossref
Crossref
Nadire Özenver. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
131
154
.
Guillaume Fond, A. Picot, A. Bourbon, M. Boucekine, P. Auquier, C. Lançon & L. Boyer. (2020) Prevalence and associated factors of cannabis consumption in medical students: the BOURBON nationwide study. European Archives of Psychiatry and Clinical Neuroscience 271:5, pages 857-864.
Crossref
Crossref
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. (2021) “Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations. European Journal of Internal Medicine 89, pages 10-18.
Crossref
Crossref
Catherine Langlois, Stéphane Potvin, Atul Khullar & Smadar Valérie Tourjman. (2021) Down and High: Reflections Regarding Depression and Cannabis. Frontiers in Psychiatry 12.
Crossref
Crossref
Nieves Martínez-Luna, Constanza Daigre, Felipe Palma-Álvarez, Marta Perea-Ortueta, Lara Grau-López, Carlos Roncero, Eudald Castell-Panisello & Josep Antoni Ramos-Quiroga. (2019) Psychiatric Comorbidity and Addiction Severity Differences in Patients With ADHD Seeking Treatment for Cannabis or Cocaine Use Disorders. Journal of Attention Disorders 25:7, pages 978-988.
Crossref
Crossref
Dai-Hua Tsai, Simon Foster, Stéphanie Baggio, Gerhard Gmel & Meichun Mohler-Kuo. (2021) Comparison of Water Pipes vs Other Modes of Cannabis Consumption and Subsequent Illicit Drug Use in a Longitudinal Cohort of Young Swiss Men. JAMA Network Open 4:4, pages e213220.
Crossref
Crossref
Jasmine Turna & James MacKillop. (2021) Cannabis use among military veterans: A great deal to gain or lose?. Clinical Psychology Review 84, pages 101958.
Crossref
Crossref
Sana Elham Kazi, Rusina Karia & Luba Leontieva. (2021) Herbal Supplements: Can They Cause Hypomania?. Cureus.
Crossref
Crossref
Siqi Xue, M. Ishrat Husain, Haoyu Zhao & Arun V. Ravindran. (2020) Cannabis Use and Prospective Long-Term Association with Anxiety: A Systematic Review and Meta-Analysis of Longitudinal Studies: Usage du cannabis et association prospective à long terme avec l’anxiété: une revue systématique et une méta-analyse d’études longitudinales. The Canadian Journal of Psychiatry 66:2, pages 126-138.
Crossref
Crossref
Yinan Chen & Christina Le-Short. 2021. Cannabinoids and Pain. Cannabinoids and Pain
317
322
.
Caroline A. MacCallum, Lindsay A. Lo & Michael Boivin. 2021. Cannabinoids and Pain. Cannabinoids and Pain
179
188
.
Felipe Ornell, Silvia Halpern & Lisia von Diemen. 2021. Psychology of Substance Abuse. Psychology of Substance Abuse
23
41
.
Albert Stuart Reece & Gary Kenneth Hulse. (2020) Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis. BMC Public Health 20:1.
Crossref
Crossref
Lorra Garey, Hannah Olofsson, Tatyana Garza, Andrew H. Rogers, Brooke Y. Kauffman & Michael J. Zvolensky. (2020) Directional Effects of Anxiety and Depressive Disorders with Substance Use: a Review of Recent Prospective Research. Current Addiction Reports 7:3, pages 344-355.
Crossref
Crossref
Shweta J Patel, Sahar Khan, Saipavankumar M & Pousettef Hamid. (2020) The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review. Cureus.
Crossref
Crossref
Kristie Ladegard, Christian Thurstone & Melanie Rylander. (2020) Marijuana Legalization and Youth. Pediatrics 145:Supplement_2, pages S165-S174.
Crossref
Crossref
Michael J. Mason. (2020) Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder. Addictive Behaviors 104, pages 106259.
Crossref
Crossref
Anees Bahji, Callum Stephenson, Richard Tyo, Emily R. Hawken & Dallas P. Seitz. (2020) Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids. JAMA Network Open 3:4, pages e202370.
Crossref
Crossref
Patrick M. Carter, Charles A. Mouch, Jason E. Goldstick, Maureen A. Walton, Marc A. Zimmerman, Ken Resnicow & Rebecca M. Cunningham. (2020) Rates and correlates of risky firearm behaviors among adolescents and young adults treated in an urban emergency department. Preventive Medicine 130, pages 105891.
Crossref
Crossref
Haggai Sharon & Silviu Brill. (2019) Cannabis-based medicines for chronic pain management. Current Opinion in Anaesthesiology 32:5, pages 623-628.
Crossref
Crossref
James MacKillop. (2019) Priorities for a Comprehensive Post-Legalization Cannabis Research Agenda in Canada. Canadian Journal of Addiction 10:3, pages 67-71.
Crossref
Crossref
Andrea H. Weinberger, Lauren R. Pacek, Christine E. Sheffer, Alan J. Budney, Joun Lee & Renee D. Goodwin. (2019) Serious psychological distress and daily cannabis use, 2008 to 2016: Potential implications for mental health?. Drug and Alcohol Dependence 197, pages 134-140.
Crossref
Crossref
Bonnie J. Leadbeater, Megan E. Ames & Ashley N. Linden‐Carmichael. (2018) Age‐varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction 114:2, pages 278-293.
Crossref
Crossref
Cesar Leos-Toro, Vicki Rynard, Donna Murnaghan, Jo-Ann MacDonald & David Hammond. (2019) Trends in cannabis use over time among Canadian youth: 2004–2014. Preventive Medicine 118, pages 30-37.
Crossref
Crossref
Sai Krishna Tikka & Deepak Cyril D’Souza. 2019. Cannabis Use Disorders. Cannabis Use Disorders
127
155
.
David A. Gorelick. 2019. Cannabis Use Disorders. Cannabis Use Disorders
113
125
.
Charlene Joseph, Olawale Ojo, Olusegun Popoola, Heela Azizi, Tasmia Khan, Orin Pramanik, Alexa Kahn, Shazia Chaudhry, Dina Rimawi, Megha Singh, Ali Mallick, Sharon Paul, Chiedozie Ojimba & Ayodeji Jolayemi. (2018) A case of brief psychosis upon cannabis withdrawal. MOJ Addiction Medicine & Therapy 5:6.
Crossref
Crossref
Frederick S. BarrettNicolas J. SchlienzNatalie LembeckMuhammad WaqasRyan Vandrey. (2018) “Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs. Cannabis and Cannabinoid Research 3:1, pages 85-93.
Crossref
Crossref
Christine Timko, Mark Ilgen, Marie Haverfield, Alexandra Shelley & Jessica Y. Breland. (2017) Polysubstance use by psychiatry inpatients with co-occurring mental health and substance use disorders. Drug and Alcohol Dependence 180, pages 319-322.
Crossref
Crossref
Yih-Ing Hser, Larissa J. Mooney, David Huang, Yuhui Zhu, Rachel L. Tomko, Erin McClure, Chih-Ping Chou & Kevin M. Gray. (2017) Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. Journal of Substance Abuse Treatment 81, pages 53-58.
Crossref
Crossref